Vyome Holdings, Inc (HIND)
Data as of , from SEC Form 4 filings.
See up to 3 months of HIND. The 7-day demo opens the 1M and 3M ranges and puts HIND on your watchlist.
Start 7-day demoLatest HIND insider trades
About Vyome Holdings, Inc (HIND)
The SEC lists Vyome Holdings, Inc under CIK 0001427570, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
HIND Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 120,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
HIND insider transactions (Form 4)
88 Form 4 filings on record, the earliest from Aug 15, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mohanjit Jolly - Director | Grant or award | Stock Option (right to buy) | 120,000 | $0.00 | - | |
| Stanley D. Pomichter III - Director | Grant or award | Stock Option (right to buy) | 17,833 | $0.00 | - | |
| Mohanjit Jolly - Director | Grant or award | Common Stock | 454,456 | - footnote F1 | - | |
| ||||||
| John M. Tincoff III - Director | Grant or award | Stock Option (right to buy) | 17,833 | $0.00 | - | |
 Shiladitya Sengupta - Director | Grant or award | Stock Option (right to buy) | 624,432 | $0.00 | - | |
 Venkateswarlu Nelabhotla - Officer | Grant or award | Stock Option (right to buy) | 615,149 | $0.00 | - | |
| Venkateswarlu Nelabhotla - Officer | Grant or award | Common Stock | 7 | - | - | |
 Robert Dickey IV - Officer | Grant or award | Common Stock | 762 | - | - | |
HIND insider trading FAQ
What is the latest insider trade for HIND?
Vyome Holdings, Inc (HIND) had 1 insider filing in the last 90 days, with the most recent on 2026-09-03. The full record for HIND runs to 8 Form 4 filings, the earliest from 2025-08-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying HIND stock?
No insider purchases of HIND were filed in the last 90 days.
How many insiders are selling HIND stock?
No insider sales of HIND were filed in the last 90 days.
Where can I see HIND SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects HIND Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
8The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Mohanjit Jolly view on EDGAR
- - Stanley D. Pomichter III view on EDGAR
- - Mohanjit Jolly view on EDGAR
- - John M. Tincoff III view on EDGAR
- - Shiladitya Sengupta view on EDGAR
- - Venkateswarlu Nelabhotla view on EDGAR
- - Venkateswarlu Nelabhotla view on EDGAR
- - Robert Dickey IV view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where HIND's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow HIND with a 7-day demo
- HIND on your watchlist
- Every HIND Form 4 filing on record
- Up to 3 months of HIND price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
